{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:51:49Z","timestamp":1791424309199,"version":"4.3.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-037-072"],"award-info":[{"award-number":["NSTC 113-2314-B-037-072"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC114-2314-B-037-029"],"award-info":[{"award-number":["NSTC114-2314-B-037-029"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["114CM-KMU-05"],"award-info":[{"award-number":["114CM-KMU-05"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Spinal muscular atrophy (SMA) is a severe neuromuscular disease associated with a high risk of respiratory complications, yet real-world data on respiratory syncytial virus (RSV) infection in this population remain limited. This study aimed to investigate the severity, hospitalization costs, and seasonal patterns of RSV infections in patients with SMA using real-world data in Taiwan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analyzed data from Taiwan\u2019s National Health Insurance Research Database from 2009 to 2021. Patients with SMA were identified through at least two outpatient clinic visits and one hospital admission. The analysis included a cross-sectional study and a birth cohort analysis for sensitivity testing. RSV-associated hospitalizations were identified using diagnostic codes for RSV. The main outcomes included ICU admissions, ventilator use, hospitalization costs, timing of RSV onset, and seasonal infection trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study documented 914 hospitalizations in patients with SMA over 13 years, including 14 RSV infections (1.5%). All RSV-related hospitalizations were documented before age 18. In a birth cohort analysis comparing 110 patients with SMA to 2,103,997 individuals from the general population, patients with SMA demonstrated significantly higher RSV hospitalization rates (9.8% vs. 1.6%), ICU admissions (54.5% vs. 4.7%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and ventilator use (54.5% vs. 1.7%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), with a later mean onset (2.54\u2009\u00b1\u20092.05 years vs. 1.05\u2009\u00b1\u20091.05 years;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0073) and substantially higher hospitalization costs (median 967 [560-6,462] USD vs. 683 [487\u20131002] USD;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0480). Infections peaked in fall and winter (72.7%) for patients with SMA. ICU admission rates for RSV increased with age and decreased with later SMA onset.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with SMA are at heightened risk for severe RSV infections even beyond infancy, underscoring the need for age-specific and seasonal prevention strategies, particularly for those over two years old.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04494-0","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:13:43Z","timestamp":1784002423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Burden of respiratory syncytial virus in spinal muscular atrophy: a retrospective nationwide cross-sectional and birth cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Hao-Wei","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia\u2011Hung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Yun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-037X","authenticated-orcid":false,"given":"Fu-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"1","key":"4494_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS. Spinal muscular atrophy. Nat Rev Dis Primers. 2022;8(1):52.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"4494_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth B. Spinal Muscular Atrophy: In the Challenge Lies a Solution. Trends Neurosci. 2021;44(4):306\u201322.","journal-title":"Trends Neurosci"},{"issue":"5","key":"4494_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52(5):518\u201323.","journal-title":"Arch Neurol"},{"issue":"8","key":"4494_CR4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2007;22(8):946\u201351.","journal-title":"J Child Neurol"},{"issue":"1","key":"4494_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, et al. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"4494_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1017\/cjn.2024.1","volume":"51","author":"TR Price","year":"2024","unstructured":"Price TR, Hodgkinson V, Westbury G, et al. A Study on the Incidence and Prevalence of 5q Spinal Muscular Atrophy in Canada Using Multiple Data Sources. Can J Neurol Sci. 2024;51(5):660\u201371.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"4494_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1099-0496(200002)29:2<141::AID-PPUL9>3.0.CO;2-Y","volume":"29","author":"D Gozal","year":"2000","unstructured":"Gozal D. Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy. Pediatr Pulmonol. 2000;29(2):141\u201350.","journal-title":"Pediatr Pulmonol"},{"key":"4494_CR8","doi-asserted-by":"publisher","first-page":"1366943","DOI":"10.3389\/fped.2024.1366943","volume":"12","author":"L Lagae","year":"2024","unstructured":"Lagae L, Proesmans M, Van den Hauwe M, et al. Respiratory morbidity in patients with spinal muscular atrophy \u2014 a changing world in the light of disease-modifying therapies. Front Pediatr. 2024;12:1366943.","journal-title":"Front Pediatr"},{"issue":"3","key":"4494_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197\u2013207.","journal-title":"Neuromuscul Disord"},{"issue":"10340","key":"4494_CR10","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047\u201364.","journal-title":"Lancet"},{"issue":"10","key":"4494_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/jpids\/piab017","volume":"10","author":"EB Rose","year":"2021","unstructured":"Rose EB, Dahl RM, Havers FP, Peacock G, Langley GE. Respiratory Syncytial Virus Associated Hospitalizations in Children With Neurological Disorders, 2006\u20132015. J Pediatr Infect Dis Soc. 2021;10(10):951\u20137.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"4494_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jpeds.2015.12.029","volume":"171","author":"SN Chiu","year":"2016","unstructured":"Chiu SN, Shao PL, Chen HC, et al. Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area. J Pediatr. 2016;171:25\u2013e301.","journal-title":"J Pediatr"},{"issue":"2","key":"4494_CR13","doi-asserted-by":"publisher","first-page":"020416","DOI":"10.7189\/jogh.05.020416","volume":"5","author":"T Shi","year":"2015","unstructured":"Shi T, Balsells E, Wastnedge E, et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis. J Glob Health. 2015;5(2):020416.","journal-title":"J Glob Health"},{"issue":"6","key":"4494_CR14","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/INF.0000000000004270","volume":"43","author":"HY Ma","year":"2024","unstructured":"Ma HY, Lin IF, Liu YC, et al. Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children. Pediatr Infect Dis J. 2024;43(6):487\u201392.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4494_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","volume":"22","author":"JW Day","year":"2022","unstructured":"Day JW, Howell K, Place A, et al. Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr. 2022;22(1):632.","journal-title":"BMC Pediatr"},{"key":"4494_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, et al. Taiwan\u2019s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"key":"4494_CR17","doi-asserted-by":"publisher","first-page":"101447","DOI":"10.1016\/j.lanepe.2025.101447","volume":"58","author":"G Dallagiacoma","year":"2025","unstructured":"Dallagiacoma G, Lundholm C, Smew AI, et al. Risk factors for severe outcomes of respiratory syncytial virus infection in children: a nationwide cohort study in Sweden. Lancet Reg Health Eur. 2025;58:101447.","journal-title":"Lancet Reg Health Eur"},{"issue":"3","key":"4494_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pds.2087","volume":"20","author":"CL Cheng","year":"2011","unstructured":"Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011;20(3):236\u201342.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"4494_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12916-023-02932-5","volume":"21","author":"B Cong","year":"2023","unstructured":"Cong B, Dighero I, Zhang T, et al. Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic analysis. BMC Med. 2023;21(1):224.","journal-title":"BMC Med"},{"issue":"6","key":"4494_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/INF.0b013e31805d01e3","volume":"26","author":"A Wilkesmann","year":"2007","unstructured":"Wilkesmann A, Ammann RA, Schildgen O, et al. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J. 2007;26(6):485\u201391.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4494_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/INF.0000000000001340","volume":"36","author":"P Manzoni","year":"2017","unstructured":"Manzoni P, Paes B, Lanct\u00f4t KL, et al. Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study. Pediatr Infect Dis J. 2017;36(1):2\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"4494_CR22","doi-asserted-by":"crossref","unstructured":"Chi H, Chung CH. Respiratory syncytial virus outbreak in infants and young children during COVID-19 pandemic in taiwan. Children (Basel). 2023;10(4):629.","DOI":"10.3390\/children10040629"},{"issue":"4","key":"4494_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/thoraxjnl-2020-215488","volume":"76","author":"SY Leung","year":"2021","unstructured":"Leung SY, Lau SYF, Kwok KL, et al. Short-term association among meteorological variation, outdoor air pollution and acute bronchiolitis in children in a subtropical setting. Thorax. 2021;76(4):360\u20139.","journal-title":"Thorax"},{"issue":"2","key":"4494_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1056\/NEJMoa2314885","volume":"391","author":"Z Assad","year":"2024","unstructured":"Assad Z, Romain AS, Aupiais C, et al. Nirsevimab and Hospitalization for RSV Bronchiolitis. N Engl J Med. 2024;391(2):144\u201354.","journal-title":"N Engl J Med"},{"issue":"34","key":"4494_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.15585\/mmwr.mm7234a4","volume":"72","author":"JM Jones","year":"2023","unstructured":"Jones JM, Fleming-Dutra KE, Prill MM, et al. Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(34):920\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"4494_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/INF.0000000000002297","volume":"38","author":"DY Wang","year":"2019","unstructured":"Wang DY, Saleem M, Paes BA, et al. Respiratory Syncytial Virus Prophylaxis in Neurologic and Muscular Disorders in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab. Pediatr Infect Dis J. 2019;38(8):775\u201380.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"4494_CR27","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/jp.2016.113","volume":"36","author":"KK McLaurin","year":"2016","unstructured":"McLaurin KK, Stockwell MS, Engel-Smith RN, Weycker D, Kuppermann E, Patel V, Nyaku MK, Kempel AG, Wade SW. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants. J Perinatol. 2016;36(11):990\u20136.","journal-title":"J Perinatol"},{"issue":"1","key":"4494_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13023-022-02227-7","volume":"17","author":"ES Veldhoen","year":"2022","unstructured":"Veldhoen ES, Wijngaarde CA, Hulzebos EH, et al. Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study. Orphanet J Rare Dis. 2022;17(1):70.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4494_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12879-022-07659-x","volume":"22","author":"PT Tran","year":"2022","unstructured":"Tran PT, Nduaguba SO, Diaby V, Choi Y, Winterstein AG. RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databases. BMC Infect Dis. 2022;22(1):681.","journal-title":"BMC Infect Dis"},{"key":"4494_CR30","doi-asserted-by":"publisher","first-page":"108181","DOI":"10.1016\/j.ijid.2025.108181","volume":"162","author":"TH Chang","year":"2026","unstructured":"Chang TH, Hu YL, Chen WC, et al. Age redistribution and altered RSV seasonality in Taiwan: A multicenter analysis from 2015 to 2023. Int J Infect Dis. 2026;162:108181.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"4494_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1086\/650486","volume":"50","author":"HK Talbot","year":"2010","unstructured":"Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010;50(5):747\u201351.","journal-title":"Clin Infect Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04494-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:17:44Z","timestamp":1791422264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04494-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4494"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04494-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Institutional Review Board of the Chi Mei Medical Center (IRB number: 11105-E04). Informed consent was waived due to the de-identified nature of the retrospective patient information. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and complied with relevant local regulations and institutional policies.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"351"}}